Literature DB >> 10993659

Major hepatic resection may suppress the growth of tumours remaining in the residual liver.

H Yokoyama1, S Goto, C L Chen, T L Pan, K Kawano, S Kitano.   

Abstract

Little is known as to how hepatectomy is associated with the growth of hepatic tumours, which may reside in the remaining liver after curative resection for hepatocellular carcinoma. Using an intra-hepatic tumour implantation model in rats, the effects of hepatectomy on tumour growth in the remaining liver were investigated. On post-operative day 7, the tumour weight in the remaining liver following 30% hepatectomy was 0.321+/-0.058 g (mean +/- SD) which was significantly greater than that (0.245+/-0.040 g) in sham operations (P<0.05). However, the tumour weight (0.156+/-0.067 g) in the remaining liver following 60% hepatectomy was significantly lower than that in sham animals (P< 0.005). The number of TdT-mediated dUTP nick-end labelling (TUNEL) positive tumour cells was significantly increased in 60% hepatectomy as compared with the sham and 30% hepatectomy group. The mRNA expression of TGF-beta1, TNF-alpha and Fas in the tumour portion of 60% hepatectomy, was higher than that in 30% hepatectomy group. Plasma levels of TGF-beta1 were inversely correlated with intra-hepatic tumour weights. These results suggest that major hepatic resection may lead to an increased induction of apoptosis for the remaining hepatic tumour. Copyright 2000 Cancer Research Campaign.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10993659      PMCID: PMC2363560          DOI: 10.1054/bjoc.2000.1379

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  33 in total

1.  Anti-Fas on nonhematopoietic tumors: levels of Fas/APO-1 and bcl-2 are not predictive of biological responsiveness.

Authors:  L B Owen-Schaub; R Radinsky; E Kruzel; K Berry; S Yonehara
Journal:  Cancer Res       Date:  1994-03-15       Impact factor: 12.701

2.  Hepatectomy prolongs survival of mice with induced liver metastases.

Authors:  M H Castillo; R J Doerr; N Paolini; S Cohen; M Goldrosen
Journal:  Arch Surg       Date:  1989-02

3.  Partial hepatectomy augments the liver's antitumor response.

Authors:  R Doerr; M Castillo; P Evans; N Paolini; M Goldrosen; S A Cohen
Journal:  Arch Surg       Date:  1989-02

4.  The fas and fas ligand pathways in liver allograft tolerance.

Authors:  T L Pan; S Goto; Y C Lin; R Lord; K C Chiang; C Y Lai; Y S Chen; H L Eng; Y F Cheng; T Tatsuma; S Kitano; C L Lin; C L Chen
Journal:  Clin Exp Immunol       Date:  1999-10       Impact factor: 4.330

5.  Postoperative recurrence of hepatocellular carcinoma.

Authors:  T Nagao; S Inoue; F Yoshimi; M Sodeyama; Y Omori; T Mizuta; N Kawano; Y Morioka
Journal:  Ann Surg       Date:  1990-01       Impact factor: 12.969

6.  Recurrent form of hepatocellular carcinoma after partial hepatic resection.

Authors:  T Ezaki; H Yukaya; Y Ogawa; Y C Chang; N Nagasue
Journal:  Hepatogastroenterology       Date:  1989-06

7.  A reproducible rat liver cancer model for experimental therapy: introducing a technique of intrahepatic tumor implantation.

Authors:  R Yang; F J Rescorla; C R Reilly; P R Faught; N T Sanghvi; L Lumeng; T D Franklin; J L Grosfeld
Journal:  J Surg Res       Date:  1992-03       Impact factor: 2.192

8.  Fas antigen and p55 TNF receptor signal apoptosis through distinct pathways.

Authors:  G H Wong; D V Goeddel
Journal:  J Immunol       Date:  1994-02-15       Impact factor: 5.422

9.  In vitro apoptosis in the human hepatoma cell line induced by transforming growth factor beta 1.

Authors:  J K Lin; C K Chou
Journal:  Cancer Res       Date:  1992-01-15       Impact factor: 12.701

10.  Complete regression of mouse hepatoma transplanted after partial hepatectomy and the immunological mechanism of such regression.

Authors:  M Ono; N Tanaka; K Orita
Journal:  Cancer Res       Date:  1986-10       Impact factor: 12.701

View more
  4 in total

1.  Major but not minor hepatectomy accelerates engraftment of extrahepatic tumor cells.

Authors:  Kathrin Rupertus; Otto Kollmar; Claudia Scheuer; Bastian Junker; Michael D Menger; Martin K Schilling
Journal:  Clin Exp Metastasis       Date:  2007-01-27       Impact factor: 5.150

2.  Angiogenesis: multiple masks in hepatocellular carcinoma and liver regeneration.

Authors:  Ji-An Chen; Ming Shi; Jin-Qing Li; Chao-Nan Qian
Journal:  Hepatol Int       Date:  2010-07-29       Impact factor: 6.047

3.  Herbal compound "Songyou Yin" reinforced the ability of interferon-alfa to inhibit the enhanced metastatic potential induced by palliative resection of hepatocellular carcinoma in nude mice.

Authors:  Xiu-Yan Huang; Zi-Li Huang; Lu Wang; Yong-Hua Xu; Xin-Yu Huang; Kai-Xing Ai; Qi Zheng; Zhao-You Tang
Journal:  BMC Cancer       Date:  2010-10-25       Impact factor: 4.430

4.  Elevated MTSS1 expression associated with metastasis and poor prognosis of residual hepatitis B-related hepatocellular carcinoma.

Authors:  Xiu-Yan Huang; Zi-Li Huang; Bin Xu; Zi Chen; Thomas Joseph Re; Qi Zheng; Zhao-You Tang; Xin-Yu Huang
Journal:  J Exp Clin Cancer Res       Date:  2016-05-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.